Viewpoint: Why we shouldn’t be deterred by CRISPR’s ‘rollercoaster year’

shutterstock e
Image credit: Shutterstock

Despite spooking investors, new insights into DNA repair and the CRISPR gene-editing system are part and parcel of its progress from research tool to human therapy.

It’s been a rollercoaster year for companies developing CRISPR gene-editing therapies. In January, a study posted on the preprint server bioRxiv raised concerns about the potential immunogenicity of CRISPR–Cas9. In March, Nature Methods retracted a study that had suggested unexpected extensive off-target mutations arising from Cas9 activity in mice. In June, two studies in Nature Medicine revealed a role for the tumor suppressor protein p53 in antagonizing Cas9 genome editing. Now a study published in our pages by Allan Bradley and colleagues reports that in addition to off-target mutations, Cas9 can sometimes induce extensive on-target DNA damage, including large deletions, inversions and insertions.

Related article:  Australian scientists eager to begin CRISPR crop research as deregulation deadline nears

Many companies are already exploring solutions to these concerns. At UMass’ RNA Therapeutics meeting in May, Caribou Biosciences disclosed efforts to address off-target issues by chemical modifications and base substitutions in the guide RNA. Others are improving the specificity of Cas9 through combined rational design, directed evolution and screening for more selective variants.

[O]ur knowledge of CRISPR–Cas gene editing and DNA repair is progressing. The picture may not be as clear as we would like. But rarely in biology does anything turn out to be as neat and simple as we imagine.

Read full, original post: Keep calm and edit on

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend